THE ADDITION OF ONE OR MORE BIOLOGICS TO METHOTREXATE IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS INCREASES THE INCIDENCE OF INFECTIONS AND SERIOUS ADVERSE EVENTS. THE 5882 PHARMACHILD COHORT

  • J. Swart
  • , A. Pistorio
  • , F. Bovis
  • , E. Alekseeva
  • , M. Hofer
  • , S. Nielsen
  • , J. Anton
  • , A. Consolaro
  • , V. Panaviene
  • , V. Stanevicha
  • , M. Trachana
  • , C. Ailioaie
  • , P. Quartier
  • , F. De Benedetti
  • , E. Tsitsami
  • , B. Flato
  • , P. Dolezalova
  • , T. Constantin
  • , T. Herlin
  • , S. Kamphuis
  • S. Sawhney, D. Maritsi, V. Vargova, L. Villa, C. Pallotti, A. Ravelli, A. Martini, N. Wulffraat, N. Ruperto

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)91-91
JournalAnnals of the Rheumatic Diseases
Volume74
Issue numberSuppl.2
DOIs
Publication statusPublished - Jun 2015
Externally publishedYes

Field of Science*

  • 3.2 Clinical medicine

Publication Type*

  • 3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Cite this